Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Feb 21;28(12):2579–2586. doi: 10.1158/1078-0432.CCR-21-3951

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

©2022 The Authors; Published by the American Association for Cancer Research

This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license.

PMC Copyright notice

Figure 2. Shorter OS in patients with detectable circulating tumor DNA. A, PFS and (B) OS by pretreatment ctDNA detection in patients with advanced, unresectable of metastatic LMS. C, PFS and (D) OS by ctDNA detection after completion of two cycles of chemotherapy in patients with advanced, unresectable, or metastatic LMS. — Shorter OS in patients with detectable circulating tumor DNA. A, PFS and (B) OS by pretreatment ctDNA detection in patients with advanced, unresectable, or metastatic LMS. C, PFS and (D) OS by ctDNA detection after completion of two cycles of chemotherapy in patients with advanced, unresectable, or metastatic LMS.